• Chart
  • F&O
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Syngene Share Price

    Syngene International Share PriceSyngene International

    Large Cap 8.7k Result
    ₹770.6
    -7.05 (-0.91%)
    As on 22 September, 2023 | 14:49 BSE: 539268 NSE: SYNGENEISIN: INE398R01022

    Syngene International Performance

    Day Range

    • Low 762.95
    • High 785.5
    770.6

    52 Week Range

    • Low 535.1
    • High 860.25
    770.6
    • Open Price773
    • Previous Close777.65
    • Volume823395

    Start SIP in Syngene International

    Start SIP

    Syngene International Share Price

    • Over 1 Month -4.39%
    • Over 3 Month 3.99%
    • Over 6 Month 33.98%
    • Over 1 Year 37.39%

    Syngene International Key Statistics

    P/E Ratio 64
    PEG Ratio 2.7
    Market Cap Cr 30,979
    Price to Book Ratio 8.6
    EPS 11.7
    Dividend 0.1
    Relative Strength Index 39.27
    Money Flow Index 63.48
    MACD Signal 7.93
    Average True Range 23.56

    Syngene International F&O

    Syngene International Futures
    Syngene International Option Chain

    Syngene International Investment Rating

    • Master Rating:

    • Syngene Inter has an operating revenue of Rs. 3,356.50 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 19% is great, ROE of 12% is good. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 15% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 92 indicates it belongs to a poor industry group of Medical-Research Eqp/Svc and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Syngene International Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 716994787768645759
    Operating Expenses Qtr Cr 552678556552473509
    Operating Profit Qtr Cr 163316230216172249
    Depreciation Qtr Cr 898895908680
    Interest Qtr Cr 610141296
    Tax Qtr Cr 165230281931
    Net Profit Qtr Cr 7518911010273147
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 3,2642,654
    Operating Expenses Annual Cr 2,2591,808
    Operating Profit Annual in Cr 934793
    Depreciation Cr 359310
    Interest Annual Cr 4524
    Tax Annual Cr 12888
    Net Profit Annual Cr 473394
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 838582
    Cash from Investing Activity Annual Cr -688-612
    Cash from Financing Annual Activity Cr -340-31
    Net Cash Flow Annual Cr -190-61
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 3,6193,292
    Fixed Assets Annual Cr 2,3862,739
    Total Non Current Assets Annual Cr 2,9643,357
    Total Current Assets Annual Cr 2,8842,204
    Total Assets Annual Cr 5,8485,561
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 9082
    ROE Annual % 1312
    ROCE Annual % 1412
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3133
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 808994786768645758
    Operating Expenses Qtr Cr 596680555552472508
    Operating Profit Qtr Cr 212314231217173250
    Depreciation Qtr Cr 1029695908680
    Interest Qtr Cr 1110141296
    Tax Qtr Cr 305230281931
    Net Profit Qtr Cr 9317911010274148
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 3,2642,657
    Operating Expenses Annual Cr 2,2591,808
    Operating Profit Annual in Cr 934796
    Depreciation Cr 367310
    Interest Annual Cr 4524
    Tax Annual Cr 12989
    Net Profit Annual Cr 464396
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 824581
    Cash from Investing Activity Annual Cr -656-612
    Cash from Financing Annual Activity Cr -343-31
    Net Cash Flow Annual Cr -175-62
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 3,6183,298
    Fixed Assets Annual Cr 2,8442,739
    Total Non Current Assets Annual Cr 3,4063,358
    Total Current Assets Annual Cr 2,4252,206
    Total Assets Annual Cr 5,8315,564
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 9082
    ROE Annual % 1312
    ROCE Annual % 1412
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3133

    Syngene International Technicals

    EMA & SMA

    Current Price
    ₹770.6
    -7.05 (-0.91%)
    • Bullish Moving Average
    • ___
    • 5
    • Bearish Moving Average
    • ___
    • 11
    • 20 Day
    • ₹809.53
    • 50 Day
    • ₹793.54
    • 100 Day
    • ₹757.63
    • 200 Day
    • ₹705.31
    • 20 Day
    • ₹805.38
    • 50 Day
    • ₹799.9
    • 100 Day
    • ₹762.29
    • 200 Day
    • ₹675.13

    Syngene International Resistance and Support

    PIVOT
    ₹787.05
    Resistance
    First Resistance ₹798.9
    Second Resistance ₹820.15
    Third Resistance ₹832
    RSI 39.28
    MFI 63.48
    MACD Single Line 7.93
    MACD 3.49
    Support
    First Resistance ₹765.8
    Second Resistance ₹753.95
    Third Resistance ₹732.7

    Syngene International Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 1,464,061 93,275,326 63.71
    Week 1,707,203 102,278,547 59.91
    1 Month 971,071 52,369,882 53.93
    6 Month 714,832 35,184,025 49.22

    Syngene International Result Highlights

    Syngene International Synopsis

    NSE-Medical-Research Eqp/Svc

    Syngene Internationa is involved in the business activities of Scientific research and development. Company’s Total Operating Revenue is Rs. 3193.50 Cr. and Equity Capital is Rs. 401.40 Cr. for the Year ended 31/03/2023. Syngene International Ltd. is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937.
    Market Cap 31,263
    Sales 3,265
    Shares in Float 18.09
    No of funds 315
    Yield 0.06
    Book Value 8.63
    U/D Vol ratio 1.4
    LTDebt / Equity 14
    Alpha 0.09
    Beta 0.51

    Syngene International

    Owner NameJun-23Mar-23Dec-22Sep-22
    Promoters 54.8%54.88%64.86%64.86%
    Mutual Funds 8.58%8.35%5.01%4.78%
    Insurance Companies 0.85%0.56%0.32%0.17%
    Foreign Portfolio Investors 23.19%23.31%16.87%16.79%
    Financial Institutions/ Banks 0.01%
    Individual Investors 8.11%8.4%8.57%8.82%
    Others 4.47%4.5%4.37%4.57%

    Syngene International Management

    Name Designation
    Ms. Kiran Mazumdar Shaw Non Executive Chairman
    Mr. Jonathan Hunt Managing Director & CEO
    Prof. Catherine Rosenberg Non Executive Director
    Ms. Vinita Bali Lead Independent Director
    Dr. Vijay Kuchroo Independent Director
    Dr. Carl Decicco Independent Director
    Ms. Sharmila Abhay Karve Independent Director
    Dr. Kush Parmar Independent Director
    Mr. Paul Blackburn Independent Director

    Syngene International Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Syngene International Corporate Action

    Date Purpose Remarks
    2023-07-26 Quarterly Results
    2023-04-26 Audited Results & Final Dividend
    2023-01-23 Quarterly Results
    2022-10-19 Quarterly Results
    2022-07-20 Quarterly Results
    Date Purpose Remarks
    2023-06-30 FINAL Rs.0.50 per share(5%)Final Dividend
    2022-07-01 FINAL Rs.0.50 per share(5%)Final Dividend
    2022-07-01 SPECIAL Rs.0.50 per share(5%)Special Dividend

    Syngene International MF Shareholding

    Name Amount(cr)
    HDFC Balanced Advantage Fund Growth 61599
    Kotak Equity Arbitrage Fund Growth 25860
    UTI Flexi Cap Fund Regular Plan Growth 25612
    SBI Arbitrage Opportunities Fund Regular Growth 17701
    ICICI Prudential Equity Arbitrage Fund Regular Growth 12496
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Syngene International FAQs

    What is Share Price of Syngene International ?

    Syngene International share price is ₹770 As on 22 September, 2023 | 14:35

    What is the Market Cap of Syngene International ?

    The Market Cap of Syngene International is ₹30979.3 Cr As on 22 September, 2023 | 14:35

    What is the P/E ratio of Syngene International ?

    The P/E ratio of Syngene International is 64 As on 22 September, 2023 | 14:35

    What is the PB ratio of Syngene International ?

    The PB ratio of Syngene International is 8.6 As on 22 September, 2023 | 14:35

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Enter Mobile Number

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.